Gainers
• Profound Medical, Inc. PROF shares increased by 14.8% to $13.75 during Tuesday's regular session.
• SINTX Technologies, Inc. SINT stock moved upwards by 11.3% to $1.68.
• PAVmed, Inc. PAVM shares rose 8.2% to $1.58.
• CytoSorbents, Inc. CTSO shares moved upwards by 8.0% to $4.85.
• InMode, Inc. INMD shares rose 7.5% to $47.18. The most recent rating by Roth Capital, on December 19, is at Buy, with a price target of $13.00.
• Hancock Jaffe, Inc. HJLI shares surged 5.7% to $0.49.
• Viemed Healthcare, Inc. VMD stock surged 5.0% to $5.65.
• Second Sight Medical, Inc. EYES shares rose 4.6% to $4.53. The most recent rating by Dougherty & Co., on December 13, is at Buy, with a price target of $2.00.
• Titan Medical, Inc. TMDI shares moved upwards by 4.3% to $0.49.
• Beyond Air, Inc. XAIR shares increased by 4.0% to $6.45.
• Venus Concept, Inc. VERO stock rose 3.9% to $6.06. The most recent rating by Maxim Group, on January 09, is at Buy, with a price target of $10.00.
• Alphatec Holdings, Inc. ATEC shares surged 3.4% to $6.46.
• Digirad, Inc. DRAD shares rose 3.2% to $2.90.
Losers
• Lianluo Smart, Inc. LLIT shares fell 30.6% to $1.91 during Tuesday's regular session.
• Allied Healthcare Prods, Inc. AHPI shares declined 29.2% to $3.08.
• Aethlon Medical, Inc. AEMD shares fell 14.4% to $3.40.
• CHF Solutions, Inc. CHFS shares plummeted 7.7% to $0.41.
• Helius Medical Tech, Inc. HSDT shares fell 6.6% to $1.13.
• Inspire Medical Systems, Inc. INSP stock decreased by 5.4% to $74.26. The most recent rating by Oppenheimer, on January 28, is at Underperform, with a price target of $50.00.
• Medigus, Inc. MDGS shares declined 5.0% to $1.80.
• ThermoGenesis Holdings, Inc. THMO stock declined 3.9% to $5.12.
• Ra Medical Systems, Inc. RMED shares plummeted 3.8% to $1.78.
• Conformis, Inc. CFMS shares plummeted 3.7% to $1.04.
• SeaSpine Holdings, Inc. SPNE stock plummeted 3.5% to $13.87. According to the most recent rating by Wells Fargo, on December 12, the current rating is at Underweight.
• NanoVibronix, Inc. NAOV stock fell 3.5% to $2.80.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.